Thérapie par cellules souches: A Novel Approach for Early-Stage Chronic Kidney Disease
Maladie rénale chronique (MRC) est un problème de santé mondial, affectant des millions de personnes dans le monde. Current treatment options for CKD are limited, and most patients eventually progress to end-stage renal disease (IRT) nécessitant une dialyse ou une transplantation. Thérapie par cellules souches has emerged as a promising approach for treating early-stage CKD, offering the potential to repair damaged kidney tissue and restore function.
Explorer le potentiel des cellules souches dans la réparation rénale
Stem cells are undifferentiated cells that have the ability to develop into various specialized cell types. Dans le contexte de la MRC, stem cells can be derived from various sources, y compris la moelle osseuse, tissu adipeux, and the kidneys themselves. These stem cells can be directed to differentiate into functional kidney cells, comme les podocytes et les cellules épithéliales tubulaires, which are crucial for kidney function. By replacing damaged or lost kidney cells, stem cells can potentially restore kidney function and slow or halt the progression of CKD.
